Joincare Pharmaceutical Group Stock Short Ratio
| 600380 Stock | 11.12 0.05 0.45% |
Joincare Pharmaceutical Group fundamentals help investors to digest information that contributes to Joincare Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Joincare Stock. The fundamental analysis module provides a way to measure Joincare Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Joincare Pharmaceutical stock.
Joincare | Short Ratio |
Joincare Pharmaceutical Group Company Short Ratio Analysis
Joincare Pharmaceutical's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Joincare Pharmaceutical Group has a Short Ratio of 0.0 times. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all China stocks average (which is currently at 0.0).
Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Joincare Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0544 | ||||
| Profit Margin | 0.09 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 11.63 B | ||||
| Shares Outstanding | 1.87 B | ||||
| Shares Owned By Insiders | 50.41 % | ||||
| Shares Owned By Institutions | 9.87 % | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 1.31 X | ||||
| Revenue | 16.65 B | ||||
| Gross Profit | 10.76 B | ||||
| EBITDA | 4.3 B | ||||
| Net Income | 1.44 B | ||||
| Total Debt | 2.08 B | ||||
| Book Value Per Share | 7.73 X | ||||
| Cash Flow From Operations | 3.93 B | ||||
| Earnings Per Share | 0.78 X | ||||
| Target Price | 13.68 | ||||
| Number Of Employees | 14.37 K | ||||
| Beta | 0.44 | ||||
| Market Capitalization | 20.8 B | ||||
| Total Asset | 36.36 B | ||||
| Retained Earnings | 9.44 B | ||||
| Working Capital | 14.01 B | ||||
| Net Asset | 36.36 B | ||||
| Last Dividend Paid | 0.18 |
About Joincare Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Joincare Pharmaceutical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Joincare Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Joincare Pharmaceutical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Joincare Stock
Joincare Pharmaceutical financial ratios help investors to determine whether Joincare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Joincare with respect to the benefits of owning Joincare Pharmaceutical security.